Page last updated: 2024-09-03

3,3'-dipropyl-2,2'-thiadicarbocyanine and Breast Cancer

3,3'-dipropyl-2,2'-thiadicarbocyanine has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mi, MT; Wei, N; Zhou, Y1

Other Studies

1 other study(ies) available for 3,3'-dipropyl-2,2'-thiadicarbocyanine and Breast Cancer

ArticleYear
Influences of lovastatin on membrane ion flow and intracellular signaling in breast cancer cells.
    Cellular & molecular biology letters, 2007, Volume: 12, Issue:1

    Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Calcium; Carbocyanines; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Female; Fluorescence; Gap Junctions; Gene Expression Regulation, Neoplastic; Humans; Ion Transport; Lovastatin; Membrane Potentials; Microscopy, Confocal; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Plasma Membrane Calcium-Transporting ATPases; RNA, Messenger; Signal Transduction

2007